1/20 Hello everyone, welcome to www.kireportscommunity.org #Nephsky #Medsky Welcome to a #skytorial brought to you by @KIReports

NephJC Short: The Push Trial — NephJC Water, water everywhere. Can a wink, a nudge and a push increase water intake to decrease kidney stone formation?

🚨 #NephJC short 🩳from @kidneyboy.bsky.social
The PUSH trial!
😉Can a wink, a nudge & a push encourage kidney stone formers to drink more fluid to prevent recurrence 🪨?
(Hint: have 💦 behavioral trials worked in CHF or PCKD?)
#NephSky #MedSky
www.nephjc.com/news/2026/4/2/nephjc-short-the-push-trial

Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis ca. 2025 from @asnpublications.bsky.social
#Nephpearls #NephSky

#VisualAbstract by @husamjz.bsky.social

👉 pubmed.ncbi.nlm.nih.gov/41433104/

VALIANT: The Visual Abstract — NephJC The VALIANT phase 3 RCT shows that proximal C3 inhibition with pegcetacoplan leads to a significantly greater reduction in proteinuria compared with placebo in patients with C3G and primary immune-com...

Check out the VA for VALIANT from @nephromommy-akshu.bsky.social
#NephJC
www.nephjc.com/news/2026/1/11/valiant-the-visual-abstract

Home-based #Exercise Improves #Muscle #Oxidative Capacity in #Kidney #Disease

#VisualAbstract by Husam Alzayer

www.kireports.org/article/S2468-0249(25)00...

Gwenaelle Begue Armin Ahmadi, PhD Bob Roshanravan

1/10
Welcome to #TenPostNephJC
Last #NephJC we discussed the PISCES study 🐟 on the role of fish oil on cardiovascular events in hemodialysis patients. This study was presented at Kidney Week with simultaneous publication, and was as unexpected as a shark attack🦈.

We are live

The @theisn.org launches a new journal

www.sciencedirect.com/journal/kidn...

Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?

Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil

Advance #Care Planning in #Dialysis Patients with a #Conversation #Game

#VisualAbstract by Husam Alzayer

www.kireports.org/article/S2468-0249(25)00...

Attacking the Origin of IgAN: ORIGIN3 and Atacicept — NephJC This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.

Tonite 11/18/25 on #Bluesky 9pm EST
We are discussing ORIGIN3 and atacicept in IgAN.
APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻)
It's going to be Wicked good. 🧙‍♀️ #NephJC
Summary by @notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36

ORIGIN-3: The Visual Abstract — NephJC Atacicept, BAFF/APRIL inhibition in IgAN

Check out the awesome visual abstract by @salinesolut.bsky.social
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract

📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Impact of Donor and Recipient Diabetes on Posttransplant Outcomes: Gradually Seeing the Wood for the Trees www.kireports.org/ar...
@husamjz.bsky.social

Diffuse Cortical Necrosis of Native Kidneys in Sickle Cell Trait: A Case Report Abstract. Introduction: Sickle cell disorders are the most common hereditary hematological disorders; sickle cell trait (SCT) is largely benign with mild clinical manifestations, if any. Renal cortica...

Glad to share our recent publication of diffuse cortical necrosis in native kidneys of a patient with #sickle_cell_trait.

Although uncommon, patients with SCT can present with end-organ damage, and vigilance should be maintained when managing these patients.

karger.com/cnd/article/...

🧵Tweetorial Alert 🧵

1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social

Bleeding, Clotting, and Kidney Disease in Atrial Fibrillation: Can Factor XI Inhibitors Change the Game? By. Husam Alzayer, MD, MSc, MRCPIReviewed by Sophia Ambruso, DOIntroduction Bleeding and thrombosis represent one of the many paradoxes faced by patients with kidney disease. As kidney function declin...

Check out the latest @kireports.bsky.social community blog from @husamjz.bsky.social
Anticoagulantion in ESRD patients with atrial fibrillation:
www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g

1/10
Last #NephJC we discussed the use of nudges 🫵 #TenPostNephJC
In this study e-nudges (email) were sent to general practitioners (GPs) & patients to see if the uptake of goal-directed medical therapy (GDMT) in diabetic CKD could be increased.
Read the article 👇
pubmed.ncbi.nlm.nih.gov/40481660/

Are E-Nudges Enough to Push Guideline-Based CKD Therapy? — NephJC This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?

👉We all need little nudges to do the right thing.
Join us 6/24/25 at 9pm EST as we chat about E-Nudges to improve goal directed medical therapy (GDMT) in CKD. #NephJC #NephSky
Blog by @nephroseeker.medsky.social @dramiliflores.bsky.social @husamjz.bsky.social
www.nephjc.com/news/nudge-ckd

Kidney Outcomes in Patients With Hereditary #Transthyretin #Amyloid Nephropathy Treated With Transthyretin #Stabilizers And Gene-Silencer Therapies

#VisualAbstract by @Husamjz

www.kireports.org/ar...

🔔Skeetorial Alert 🔔

1/
Hey #NephSky #MedSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social

KDIGO 2025 ADPKD Guidelines Review — NephJC This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD.  These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, ...

Happening this week!

The @kdigo.org guidelines in #ADPKD #PKD on #NephJC

www.nephjc.com/news/adpkd-k...

Summary from @brianrifkin.bsky.social

Ugh
This is a nephrologist
(And an NSMC internship grad)

#NephSky #MedSky

Interaction Between #APOL1 #Genetic Risk and Neighborhood Socioeconomic Status for #Kidney Outcomes in a United States Cohort

#VisualAbstract by @husamjz.bsky.social

www.kireports.org/ar...

NephJC Editorial Internship — NephJC

Announcing the #NephJC internship, @nephjc.bsky.social and @kireports.bsky.social joining forces

www.nephjc.com/intern-app for details and to apply!

#NephSky

Systematic Review of the Effects of #Iron on #Cardiovascular, #Kidney and Safety Outcomes in Patients With Chronic Kidney Disease #CKD

#VisualAbstract by @Husamjz

www.kireports.org/ar...

@bernardchan33 @brendonneuen

#Pharmacokinetics and #SideEffects of Δ9-tetrahydrocannabinol and #Cannabidiol in Patients with Different Stages of Chronic Kidney Disease #CKD

#VisualAbstract by @Husamjz

www.kireports.org/ar...

1/ 🚨 NEW #5Pearls: Peripheral Artery Disease (PAD)

Let’s learn:

🚦When to suspect PAD
🚦PAD workup
🚦How to ⬆️ quality of life
🚦How to ⬇️ CV mortality
🚦Role of anti-thrombotics & anticoagulation
🚦Who needs revascularization

🖥️: t.co/dXfmA3Wx3c

Making Kidney Health a Global Priority — NephJC Let’s pus the WHO to make Kidney Health a global priority

If you haven't already - please consider signing the ISN petition for the WHO to consider kidney health as a global priority

We explain why with link to sign (takes 2 minutes - open to all)

www.nephjc.com/news/isn-who...